1002 Friday IPOs
BioCentury & Getty Images


C4 is latest preclinical protein degradation IPO with big aftermarket gain

Closely watched biotechs Foghorn, Jacobio join queue to go public

Oct 2, 2020 | 10:36 PM GMT

Public investors again showed their appetite for protein degradation companies Friday, as C4’s upsized IPO was the largest

Read the full 508 word article

How to gain access

Continue reading with a
two-week free trial.